Laureen shows you her proprietary “Bubbling and Highlighting Technique”
Download your Free copy of my "Medical Coding From Home Ebook" at the top right corner of this page
Patients are taking a more active role in their blood pressure (BP) monitoring, making it easier for physicians to diagnose and manage hypertension. “With the advance of new technologies for e-visits and health monitoring, many patients are realizing the best access point for physician care is once again their home,” said American Medical Association (AMA) […]
The post New Codes Report DIY Blood Pressure Monitoring appeared first on AAPC Knowledge Center.
Physicians are better equipped to correctly diagnose Medicare patients with hypertension thanks to a new national coverage policy. The Centers for Medicare & Medicaid Services (CMS) issued, July 2, a final decision memo regarding its national coverage policy for ambulatory blood pressure monitoring (ABPM). For nearly two decades, Medicare coverage for ABPM has been limited […]
The post Ambulatory Blood Pressure Monitoring Coverage Expanded appeared first on AAPC Knowledge Center.
Thank you in advance
What Does it Take to Get Paid? AMA Morning Rounds (Dec. 5, Henry) discusses remote patient monitoring (RPM) and the “pitfalls you will want to avoid” as your practice implements this latest telehealth service. The article discusses three “pitfalls” to watch out for: Workflow Requirements Data Key requirements of implementing RPM include the coding and […]
The post Remote Patient Monitoring appeared first on AAPC Knowledge Center.
I’m trying to get a clear definition of ‘Drug therapy requiring INTENSIVE MONITORING’ to toxicity on the Risk Table.
Google has confused me further.
I’m trying to decipher when it would be in that category verses ‘prescription drug management’ in the moderate.
An example I have that one of my Drs brought up to me is a drug called Noctiva which treats Nocturia.
One of the main side effects is hyponatremia which CAN be life-threatening. So he will need to closely monitor the patients sodium levels.
But my question is what exactly is ‘intensive monitoring for toxicity’. The internet definitely points me to when the patient is in the hospital and getting IV medications of controlled substances and such that might need to be titrated, but does this also apply to clinically monitoring? I think I read that this drug recommends checking sodium levels bi weekly or monthly.
I see that Gentamicin is on a list of requiring intensive monitoring for toxicity. We give this often for UTI’s. So, if the patient has a UTI and we give them this injection (I know I still need 2 out of 3 in MDM), but I can put it in the high spot on the risk table??